Member Info for MIKODX

UK-RTC will be the main players when it come to testing in the future. But I see many other players also being involved. This may be another reason why the SP isn't climbing higher as you would expect. Investors are unsure what is going to happen.

But overall the SP is holding strong without news. As we get closer to the end of the month the SP will get stronger with the FOMO brigade all clambering to get back in.

SIMMODBEST - AVCT trading at £1.71 might have something to do with it.

Someone needs to give their head a rattle.

Results for MRx1234 IBS trials due anytime between now and end of September.

Fri, 17th Apr 2020 07:00
RNS Number : 9582J
4d Pharma PLC



Interim analysis of Blautix phase II study data

Indicates encouraging safety profile and non-futility of study



Leeds, UK, April 17, 2020 - 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the key findings of a planned interim analysis in its BHT-II-0002 study in IBS.



BHT-II-0002 is 4D Pharma's phase II, randomized, double blind, placebo-controlled, multicentre study. It is evaluating the safety and efficacy of repeated oral doses of the company's Live Biotherapeutic, Blautix, in adult subjects with irritable bowel syndrome (IBS) subtypes IBS-C and IBS-D.

The BHT-II-0002 study interim analysis, aimed to support clinical and commercial development plans, has been conducted on a total of 246 IBS patients (118 IBS-C and 128 IBS-D). Data on around 78 additional patients who have all finished drug treatment and primary endpoint evaluations for all patients are expected to be included in the full study analysis and trial data. 4D Pharma expects to report on this full data set as planned in Q3 2020.

KilkennyTed - thanks for posting that. I'm sure it will cheer a lot of people up.

This is the kind of news we want to hear, but only after we've sold our kit to the govt :)

Nskno1 - I've worked in numerous hospitals and labs, and trust me those environments are very heavily controlled. PPE or scrubs as they call it , has to be worn at all times. We're talking potentially toxic environments, eating and drinking is strictly prohibited.

Nskno1 - If you can show me one medical laboratory in the world that has a vending machine, i'll give you all my investment :)

I need an antibody test asap, I've been waiting far too long. I want to know if these headaches I've been getting is Covid 19 or caused by investing in ODX.

TonyHX - Waste of time trying to trade this stock short term. The margin's are just not high enough. By the time you've paid broker fees, you'll see it's just a waste of time.

It was good a couple moths back when you had big swings between 50 and 80p, but not now. It only makes sense if your trading huge amounts. Your better of going somewhere like SNG where the daily swings are much higher.

Good to see you back Woodsy. Thought you got fed up and left.

I was referring to Michaelhighbar.

'All that's needed is at least ONE major successful phase III trial to address a major illness or health issue'.

then

'I was thinking of an additional even bigger success eg in the oncology or covid-19 arena'.

Make your mind up, can't have it both ways.

jabababa - I've put it up for the newbies just in case.

https://www.bloomberg.com/news/articles/2020-07-03/cineplex-says-it-starts-litigation-against-cineworld-over-merger

I think Cineplex and Cineworld will come to some agreement, it's a toss up who would win the case, although Cineworld have a slight advantage because of Covid. But as long as this case rumbles on Investors will lose confidence. Hope this gets sorted and quickly.

According to the latest updates the first quarter for CINE was better than last year's first quarter, the second quarter is obviously going to be down, because of the closures during lockdown. Added to that the pending court case, this is going to have a diverse effect on the SP. Now might be a good time to get in. But this is a strong stock with good financial backing, so I don't think it will be down for too long. If it goes down any further I will be topping up.

CORRECTION

Conversion is $1.18 I should say, and we need to stay above 76p not 90p

Notice we've finished in the 90's again. 90p converted to dollars is $1.02. Feel free to correct me if you think I'm wrong, but one of the requirements for trading on the Nasdaq is that prior to listing, you must spend at least ten days trading over the minimum amount required which is $1.

If it continues to stay in the nineties or above for the next eight working days, then there's a strong possibility this stock could be transferring over to the Nasdaq exchange. Let's see.

India and UK I'll let that go we've had updates for those. But China, Africa, and EU no updates yet. Colin if your reading this, can we have some updates for these. If Covid is holding up orders can you please let us know.

Thanks